Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

University of Iowa Researchers Identify Caffeine-Consuming Bacterium

09.06.2011
As it turns out, humans aren't the only organisms that turn to caffeine for a pick-me-up. University of Iowa scientists have identified four different bacteria that actually can live on caffeine.

One of them, known as Pseudomonas putida CBB5, was found in a flowerbed outside a UI research laboratory. The research team says the discovery -- and the new understanding of how the process works -- could in the future allow scientists to convert waste from leftover coffee, tea and even chocolate into useful substances, like pharmaceuticals, animal feed or biofuels.

Previous studies have also discovered caffeine-degrading bacteria, but the UI team took the research one step further. They identified the gene sequence that enables the bacterium to break down the caffeine compound in nature.

Caffeine is found naturally in more than 60 different plants and is composed of carbon, hydrogen, nitrogen and oxygen. Its molecular structure features three clusters of carbon and hydrogen atoms known as methyl groups, enabling caffeine to resist degradation by most bacteria.

Led by UI chemical and biochemical engineering doctoral student Ryan Summers, the study found that Pseudomonas putida CBB5 uses four newly discovered digestive proteins to break caffeine down into xanthine and then to carbon dioxide and ammonia. It removes the methyl groups from the molecule (a process called N-demethylation), allowing the bacteria to feed on the nitrogen atoms in the interior of the molecule (xanthine).

The caffeine digestive proteins from CBB5 can be used to convert caffeine into building blocks for drugs used to treat asthma, improve blood flow and stabilize heart arrhythmias.

"With one or two methyl groups removed, the remainder of the molecule can be used as the base for a number of pharmaceuticals," Summers said. "You basically use the new genes and enzymes that could take something we have a lot of -- like caffeine -- and make drugs that are typically very expensive. And that process could lower the costs for people who need them."

Summers said the bacterium's digestive proteins could also be used to remove caffeine and related compounds from large amounts of waste generated from coffee and tea processing, which pollute the environment. The decaffeinated waste from these industries could be used for animal feed, or for production of transportation fuel, especially in areas where corn (for ethanol) is scarce.

The team originally thought only one enzyme was responsible for extracting methyl groups. Ultimately, they identified four (NdmA, NdmB, NdmC, and reductase) involved in the N-demethylation process. This helped them to pinpoint the genes responsible for enzyme production in the bacterium.

Summers, with UI research scientists Michael Louie and Chi Li Yu, studied the bacterium in professor Mani Subramanian's lab in the Chemical and Biochemical Engineering Department, and the Center for Biocatalysis and Bioprocessing. They initially set out to craft a dipstick measurement for nursing mothers to test caffeine levels in breast milk, but the gene discovery took the research down a different path.

"These findings are a significant leap, as other researchers have shown bacteria can grow on caffeine, but, until now, the exact mechanism was a mystery," Subramanian said. "Now that we are starting to work on this, we are finding completely new genes, and reactions that we never expected."

Summers presented the findings at the American Society for Microbiology in New Orleans in late May. He anticipates seeking a scientific publication of the study this summer.

STORY SOURCE: University of Iowa Graduate College Office of External Relations, 205 Gilmore Hall, Iowa City, Iowa 52242-2500

Alison Sullivan | Newswise Science News
Further information:
http://www.uiowa.edu

More articles from Life Sciences:

nachricht New Technique Maps Elusive Chemical Markers on Proteins
03.07.2015 | Salk Institute for Biological Studies

nachricht New approach to targeted cancer therapy
03.07.2015 | CECAD - Cluster of Excellence at the University of Cologne

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Viaducts with wind turbines, the new renewable energy source

Wind turbines could be installed under some of the biggest bridges on the road network to produce electricity. So it is confirmed by calculations carried out by a European researchers team, that have taken a viaduct in the Canary Islands as a reference. This concept could be applied in heavily built-up territories or natural areas with new constructions limitations.

The Juncal Viaduct, in Gran Canaria, has served as a reference for Spanish and British researchers to verify that the wind blowing between the pillars on this...

Im Focus: X-rays and electrons join forces to map catalytic reactions in real-time

New technique combines electron microscopy and synchrotron X-rays to track chemical reactions under real operating conditions

A new technique pioneered at the U.S. Department of Energy's Brookhaven National Laboratory reveals atomic-scale changes during catalytic reactions in real...

Im Focus: Iron: A biological element?

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and a half billion years ago.

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and...

Im Focus: Thousands of Droplets for Diagnostics

Researchers develop new method enabling DNA molecules to be counted in just 30 minutes

A team of scientists including PhD student Friedrich Schuler from the Laboratory of MEMS Applications at the Department of Microsystems Engineering (IMTEK) of...

Im Focus: Bionic eye clinical trial results show long-term safety, efficacy vision-restoring implant

Patients using Argus II experienced significant improvement in visual function and quality of life

The three-year clinical trial results of the retinal implant popularly known as the "bionic eye," have proven the long-term efficacy, safety and reliability of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

World Conference on Regenerative Medicine in Leipzig: Last chance to submit abstracts until 2 July

25.06.2015 | Event News

World Conference on Regenerative Medicine: Abstract Submission has been extended to 24 June

16.06.2015 | Event News

MUSE hosting Europe’s largest science communication conference

11.06.2015 | Event News

 
Latest News

Siemens receives order for offshore wind power plant in Great Britain

03.07.2015 | Press release

'Déjà vu all over again:' Research shows 'mulch fungus' causes turfgrass disease

03.07.2015 | Agricultural and Forestry Science

Discovery points to a new path toward a universal flu vaccine

03.07.2015 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>